Back to Journals » Drug, Healthcare and Patient Safety » Volume 9
Original Research
Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,770 | Dovepress* | 8,473+ | 1,688 | 10,161 | |
PubMed Central* | 1,297 | 597 | 1,894 | ||
Totals | 9,770 | 2,285 | 12,055 | ||
*Since 25 October 2017 |
View citations on PubMed Central and Google Scholar